LISATA THERAPEUTICS, INC. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Lisata Therapeutics filed its Q2 2026 10-Q on August 6, 2026 for the period ending June 30, 2026. The filing document index shows standard regulatory exhibits (certifications, XBRL data) but the actual financial statements and MD&A content are not provided in the text supplied. Without access to the substantive sections, no specific dollar amounts, deal terms, or business developments can be identified.
Why this rating
Routine periodic disclosure. Filing metadata only provided; no material events, transactions, or financial data visible to assess business impact.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.